Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

Not yet recruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

December 31, 2027

Conditions
Hepatocellular Carcinoma Non-resectable
Interventions
OTHER

Fecal Microbiota Transplantation

The FMT capsules will be prepared by matching the gut microbiome profiles of healthy donors with those of patients who achieved a complete response to the triple therapy. The FMT capsules will be taken orally at a dosage of 30 capsules per day for the first 3 days of each treatment cycle. The FMT intervention will be administered in 6 cycles, with each cycle lasting for 21 days (Q3W). The duration of the treatment will be determined by the response to therapy, with a maximum of 6 cycles or until disease progression, intolerable toxicity, or participant withdrawal of consent. The FMT capsules are intended to modify the gut microbiome to reverse the resistance to the triple therapy and enhance the therapeutic response.

All Listed Sponsors
lead

Fujian Provincial Hospital

OTHER

NCT06643533 - Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004) | Biotech Hunter | Biotech Hunter